A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix

Gynecologic Oncology

Volumn 66, Issue 1, 1997, Pages 52-58

  Tseng, Chih Jen ^a   Chang, Chang Ting ^a   Lai, Chyong Huey ^a   Soong, Yung Kuei ^a   Hong, Ji Hong ^a   Tang, Simon G ^a   Hsueh, Swei ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; VINCRISTINE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

EID: 0031193576     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4721     Document Type: Article

References (32)

1. Montana G S, Fowler W C, Varia M A, Walton L A, Mack Y, Shemanski L. Carcinoma of the cervix stage III: results of radiation therapy. Cancer. 57:1986;148-154.
2. Burghardt E, Baltzer J, Harjanto-Tulusan A, Haas J. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer. 70:1992;648-655.
3. Perez C A, Camel H M, Kuske R R, Kao M S, Galakatos A, Hederman M A, Powers W E. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience. Gynecol Oncol. 23:1986;127-140.
4. Souhami B L, Gil R A, Allan S E, Canary P CV, Araujo C MM, Pinto L HJ, Silveira T RP. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIb carcinoma of the cervix. J Clin Oncol. 9:1991;970-977.
5. Stehman F B, Bundy B N, Di Saia P J, Keys H M, Larson J E, Fowler W C. Carcinoma of the cervix treated with radiation therapy. A multivariate analysis of prognostic variables in the Gynecology Oncology Group. Cancer. 67:1991;2776-2785.
6. Herskovic A, Martz K, Al-Sarraf M, Leichamn L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emani B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 326:1992;1593-1598.
7. Schaake-Koning C, van den Bogaert W, Dalesio O, Featen J, Hoogenhout J, van Houte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, Renaud A, Rodrigus P, Schuster-Uitterhoeve L, Sculier J P, van Zandwijk N, Bartelink H. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med. 326:1992;524-530.
8. Al-Sarraf M, Pajak T F, Cooper J S, Mohiuddin M, Herskovic A, Ager P J. Chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a Radiation Therapy Oncology Group study. J Clin Oncol. 8:1990;1342-1351.
9. Fields A L, Anderson P S, Goldberg G L, Wadler S, Beitler J, Sood B, Runowicz C D. Mature results of a phase II trial of concurrent cisplatin/pelvic radiotherapy for local advanced squamous cell carcinoma of the cervix. Gynecol Oncol. 61:1996;416-422.
10. John M, Flam M, Caplan R, Rotman M, Quivey J, Steinfeld A, Russell A. Final results of a phase II chemoradiation protocol for locally advanced cervical cancer: RTOG 85-15. Gynecol Oncol. 61:1996;221-226.
11. Lin J C, Ho E SC, Jan J S, Yang C H, Liu F S. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 61:1996;101-108.
12. Pearcey R G, Stuart G CE, MacLean G D, Nation J G, Arthur K, Lukka H, Jeffrey J, James K, Brundage M. Phase II study to evaluate the toxicity and efficacy of concurrent cisplatin and radiation therapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix. Gynecol Oncol. 58:1995;43-41.
13. Malfetano J, Keys H, Kredenrser D, Cunningham-Kotlove D, Weiss L. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer. 71:1993;3703-3706.
14. Ranowicz C D, Wadler S, Rodriguez-Rodriguez L, Litwin P, Shaves M, O'Hanlan K A, Goldberg G L, Tomaino C T, Byrne R s. Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. Gynecol Oncol. 34:1989;395-401.
15. Choo Y C, Choy T K, Wong L C, Ma H K. Potentiation of radiotherapy bycis. Gynecol Oncol. 23:1986;94-100.
16. Wong L C, Choo Y C, Choy D, Sham J ST, Ma H K. Long-term follow-up of potentiation of radiotherapy by cisplatinum in advanced cervical cancer. Gynecol Oncol. 35:1989;159-163.
17. Chang H C, Lai C H, Cken M S, Ckao A S, Chen L H, Soong Y K. Preliminary results of concurrent radiotherapy and chemotherapy withcis. Gynecol Oncol. 44:1992;182-188.
18. Chen M S, Lin F J, Hong C H, Tu C P, Lan J H, Tang S G, Leung W M, Wang T R. High-dose-rate afterloading technique in the radiation treatment of uterine cervical cancer: 399 cases and 9 years experience in Taiwan. Int J Radiat Oncol Biol Phys. 20:1991;915-919.
19. Miller A B, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 47:1981;207-214.
20. Blessing J A. Design and Interpretation of Chemotherapy Trials in Gynecologic Cancer. Chemotherapy of Gynecologic Cancer. 1990;Wiley-Liss, Press, New York. p. 63-97.
21. Hall E J. The Oxygen Effect and Reoxygenation. Hall E J. Radiobiology for the Radiobiologist. 1988;137-160 Lippincott, Philadelphia.
22. Sardi J E, di Paola G R, Cachau A, Ortiz O C, Sananes C, Giaroli A, Martins D, Peluffo M. A possible new trend in the management of the carcinoma of the cervix uteri. Gynecol Oncol. 25:1986;139-149.
23. Thigpen T, Shingleton H, Homesley H, Lagasse L, Blessing J. cis. Cancer. 48:1981;899-903.
24. Alberts D S, Garcia D, Mason-Liddil N. Cisplatin in advanced cancer of the cervix: an update. Semin Oncol. 18:1991;11-24.
25. Bonomi P, Blessing J A, Stehman F B, Di Saia P, Walton L, Major F. Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol. 3:1985;1079-1085.
26. Alberts D S, Masspn-Liddil N. The role of cisplatin in the management of advanced squamous cell cancer of the cervix. Semin Oncol. 16:1989;66-78.
27. Couglin C T, Richmond R C. Biological and clinical developments of cisplatin combined with radiotherapy: concepts, utility, projections for new trials, and the emergence of carboplatin. Semin Oncol. 16:1989;31-43.
28. Dewit L. Combined treatment of radiotherapy andcis. Int J Radiat Biol Phys. 13:1987;403-426.
29. Vogl S E, Moukhtar M, Calanog A, Greenwald E H, Kaplan B H. Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, andcis. Cancer Treat Rep. 64:1980;1005-1007.
30. Alberts D S, Martimbeau P W, Surwit E A, Oishi N. Mitomycin-C, bleomycin, vincristine, andcis. Cancer Clin Trials. 4:1981;313-316.
31. Berman M L, Keys H, Creasman W, DiSaia P, Bundy B, Blessing J. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 19:1984;8-16.
32. Withers H R, Taylor J MF, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.